Subscribe
e.g. organoids

BRAF/MEK Inhibition in NSCLC: Mechanisms of Resistance and How to Overcome It

Investigators discuss inhibition of BRAF and its downstream effector MEK which constitutes a therapeutic strategy for a subset of patients with NSCLC and is associated with clinical benefit.
[Clinical and Translational Oncology]
Abstract
Published In
NewslettersPulmonary Cell News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

The Establishment of Polypeptide PSMA-Targeted Chimeric Antigen Receptor-Engineered Natural Killer Cells for Castration-Resistant Prostate Cancer and the Induction of Ferroptosis-Related Cell Death

[Cancer Communications] Scientists designed a novel CAR-natural killer cells with a clinically significant tumoricidal effect on castration-resistant prostate cancer.
Cell Therapy NewsNewsletters
Read more

The Healing of Bone Defects by Cell-Free and Stem Cell-Seeded 3D-Printed PLA Tissue-Engineered Scaffolds

[Journal of Orthopaedic Surgery and Research] The authors showed that both cell-free and stem cell-seeded scaffolds exhibited superb healing compared with the empty defect controls, and new bone and connective tissues were formed in the healing site after 8 and 12 weeks, postoperatively.
Cell Therapy NewsNewsletters
Read more

Long-Term Hematopoietic Stem Cells as a Parasite Niche during Treatment Failure in Visceral Leishmaniasis

[Communications Biology] Double bioluminescent/fluorescent Leishmania infantum and L. donovani reporter lines enabled the identification of long-term hematopoietic stem cells as a niche in the bone marrow with remarkably high parasite burdens, a feature confirmed for human hematopoietic stem cells.
Hematopoiesis NewsNewsletters
Read more
Brought to you by